Park BH - Search Results

1

Deletion of PTEN promotes tumorigenic signaling, resistance to anoikis, and altered response to chemotherapeutic agents in human mammary epithelial cells.

Vitolo MI, Weiss MB, Szmacinski M, Tahir K, Waldman T, Park BH, Martin SS, Weber DJ, Bachman KE. Vitolo MI, et al. Among authors: park bh. Cancer Res. 2009 Nov 1;69(21):8275-83. doi: 10.1158/0008-5472.CAN-09-1067. Epub 2009 Oct 20. Cancer Res. 2009. PMID: 19843859 Free PMC article.

2

DNMT1 and DNMT3b cooperate to silence genes in human cancer cells.

Rhee I, Bachman KE, Park BH, Jair KW, Yen RW, Schuebel KE, Cui H, Feinberg AP, Lengauer C, Kinzler KW, Baylin SB, Vogelstein B. Rhee I, et al. Among authors: park bh. Nature. 2002 Apr 4;416(6880):552-6. doi: 10.1038/416552a. Nature. 2002. PMID: 11932749

3

Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene.

Bachman KE, Park BH, Rhee I, Rajagopalan H, Herman JG, Baylin SB, Kinzler KW, Vogelstein B. Bachman KE, et al. Among authors: park bh. Cancer Cell. 2003 Jan;3(1):89-95. doi: 10.1016/s1535-6108(02)00234-9. Cancer Cell. 2003. PMID: 12559178 Free article.

4

p21(WAF1/CIP1) mediates the growth response to TGF-beta in human epithelial cells.

Bachman KE, Blair BG, Brenner K, Bardelli A, Arena S, Zhou S, Hicks J, De Marzo AM, Argani P, Park BH. Bachman KE, et al. Among authors: park bh. Cancer Biol Ther. 2004 Feb;3(2):221-5. doi: 10.4161/cbt.3.2.666. Epub 2004 Feb 1. Cancer Biol Ther. 2004. PMID: 14726675 Free article.

5

The PIK3CA gene is mutated with high frequency in human breast cancers.

Bachman KE, Argani P, Samuels Y, Silliman N, Ptak J, Szabo S, Konishi H, Karakas B, Blair BG, Lin C, Peters BA, Velculescu VE, Park BH. Bachman KE, et al. Among authors: park bh. Cancer Biol Ther. 2004 Aug;3(8):772-5. doi: 10.4161/cbt.3.8.994. Epub 2004 Aug 26. Cancer Biol Ther. 2004. PMID: 15254419 Free article.

6

Duel nature of TGF-beta signaling: tumor suppressor vs. tumor promoter.

Bachman KE, Park BH. Bachman KE, et al. Among authors: park bh. Curr Opin Oncol. 2005 Jan;17(1):49-54. doi: 10.1097/01.cco.0000143682.45316.ae. Curr Opin Oncol. 2005. PMID: 15608513 Review.

7

Identification of compounds that inhibit growth of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine-resistant cancer cells.

Bachman KE, Sager J, Cheong I, Catto M, Bardelli A, Park BH, Vogelstein B, Carotti A, Kinzler KW, Lengauer C. Bachman KE, et al. Among authors: park bh. Mol Cancer Ther. 2005 Jun;4(6):1026-30. doi: 10.1158/1535-7163.MCT-05-0038. Mol Cancer Ther. 2005. PMID: 15956261

8

Mutation of the PIK3CA oncogene in human cancers.

Karakas B, Bachman KE, Park BH. Karakas B, et al. Among authors: park bh. Br J Cancer. 2006 Feb 27;94(4):455-9. doi: 10.1038/sj.bjc.6602970. Br J Cancer. 2006. PMID: 16449998 Free PMC article. Review.

9

Physiologic estrogen receptor alpha signaling in non-tumorigenic human mammary epithelial cells.

Abukhdeir AM, Blair BG, Brenner K, Karakas B, Konishi H, Lim J, Sahasranaman V, Huang Y, Keen J, Davidson N, Vitolo MI, Bachman KE, Park BH. Abukhdeir AM, et al. Among authors: park bh. Breast Cancer Res Treat. 2006 Sep;99(1):23-33. doi: 10.1007/s10549-006-9177-0. Epub 2006 Mar 16. Breast Cancer Res Treat. 2006. PMID: 16541319

10

Interleukin-1 alpha mediates the growth proliferative effects of transforming growth factor-beta in p21 null MCF-10A human mammary epithelial cells.

Karakas B, Weeraratna A, Abukhdeir A, Blair BG, Konishi H, Arena S, Becker K, Wood W 3rd, Argani P, De Marzo AM, Bachman KE, Park BH. Karakas B, et al. Among authors: park bh. Oncogene. 2006 Sep 7;25(40):5561-9. doi: 10.1038/sj.onc.1209540. Epub 2006 Apr 17. Oncogene. 2006. PMID: 16619041

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

981 results

Search Page

Filters